Articles On EMvision Medical Devices (ASX:EMV)

Wall Street mixed as oil and metals fall US stock markets were mixed on Monday, as oil prices fell to a three-week low on concerns about the virus spread in China and the rising US dollar. The Dow Jones fell by 0.3%, S&P 500 down by 0.0...

The ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0.80%, helped by medicinal cannabis company AusCann (ASX:AC8). It rose by 5% in morning trading. AusCann announced it has submitted the first...

Wall Street, Oil plunge on rising COVID cases All three benchmark indices in the US tumbled on Monday, as coronaviruses continue to spike around the world. The Dow Jones had its worst day this year, falling by 2.09%, S&P 500 by 1.59%, a...

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

Queensland-based EMVision Medical Devices (ASX: EMV) has reported significant advances to the design and engineering of its first-generation portable brain scanning machine prior to commercialisation. Improvements and upgrades have been mad...

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s b...

EMVision Medical Devices Ltd (ASX: EMV) shares were on the rise today following news of two significant technology and product development breakthroughs from the company. By the market’s close, the EMVision share price was trading at $3.16...

Portable brain scanning technology developed by EMVision Medical Devices (ASX: EMV) has been further enhanced by the addition of two new techniques with the potential to significantly improve the diagnosis and care of stroke patients. The c...

With health issues at the global forefront over the past year, it’s no surprise that Australia’s health-related sector has also grown substantially. But the industry was already emerging even before COVID-19. Excellent research facilities a...

The EMVision Medical Devices Ltd (ASX:EMV) share price is up more than 13%. After moving up the chart and going higher than $4 in November, the EMV share price fell away but is now pushing higher again today... The post EMvision Medical De...

The EMvision Medical Devices Ltd (ASX: EMV) share price closed 13.2% higher today after the company made a funding announcement. The EMvision share price finished off the trading session at $2.74 this afternoon. Here’s a wrap of where the...

Medical imaging technology company EMVision Medical Devices (ASX: EMV) is set to receive $8 million funding from a total $40 million pool awarded to commercial partner Australian Stroke Alliance (ASA) under the federal government’s Stage 2...

ASX health stocks EMvision (ASX:EMV) and 4D Medical (ASX:4DX) have been awarded over $37 million between them in government grants. ... Read More The post Another 2 ASX health stocks confirm they’ve received a major government grant appeare...

EMvision Medical Devices Ltd (ASX: EMV) shares are unchanged today after the company announced a trading halt before market open on Friday. At the close of market on Thursday, the EMVision share price was trading at $2.42.  Let’s take a lo...

Medical imaging technology developer EMVision Medical Devices (ASX: EMV) has elected to expand on an initial clinical study involving its portable brain scanner in stroke patients at Brisbane’s Princess Alexandra Hospital. The company has d...

Peter Switzer talks to Dr Ron Weinberger, CEO and Managing Director of EMvision (EMV).

ShareCafeHidden Gems Webinar Recap – NTI, RLG, 3DP, EMV Catch up on the full webinar with presentations from EMVision (ASX:EMV), Pointerra (ASX:3DP), Roolife Group (ASX:RLG) and Neurotech International (ASX: NTI). Hidden Gems Webinar Recap...

ShareCafeEMVision (ASX:EMV) – Hidden Gems Webinar Presentation Presenter – Scott Kirkland – Executive Director – EMVision is developing a portable brain scanner for rapid, point of care, Stroke Diagnosis, and Monitoring.The EMVT technology...

Summary The pandemic has changed the fundamentals of the way businesses work across the globe which are expected to sustain for the coming years. Some of the emerging trends can be seen in the rapid technological adoption by the busine...

The EMvision Medical Devices Ltd (ASX: EMV) share price has opened lower this morning despite the company reporting encouraging data from its pilot clinical trial. EMvision provides imaging technology for classifying different types of str...

Queensland-based EMVision Medical Devices (ASX: EMV) has reported encouraging data from a pilot clinical trial employing a prototype of its portable brain scanner on patients with diagnosed ischaemic or haemorrhagic stroke. The single-site...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

Nearly two years of pain for Factor Therapeutics (ASX:FTT) shareholders could be over soon with the company signing a term sheet to negotiate a potential acquisition. In 2018, Factor was trying to commercialise a wound-dressing drug, which...

Listed imaging technology outfit EMvision Medical Devices was fronting funds on Wednesday morning, on the hunt for fresh capital.  

EMvision Medical Devices (ASX:EMV) chief Ron Weinberger brings a rarefied perspective to the prospective device maker: he was a mover and shaker behind the $2bn market cap probe sterilising house Nanosonics (ASX:NAN). As one could imagine,...

The COVID-19 pandemic has led to 527 clinical trials being shut down in Australia and New Zealand the last two months, up 36 per cent on the prior two months as many organisations deem the patient risk of exposure to be too high. Globally,...

EMVision Medical Devices (ASX: EMV) has released what it claims is “promising” first stroke patient images from a pilot clinical trial that aims to improve the understanding of stroke on electromagnetic scattering effects in the brain. Acco...

Noxopharm (ASX:NOX) is the latest biotech to announce it will test its drug against COVID-19. So how exactly does an anti-prostate cancer drug work for COVID-19? Noxopharm says it is all about one signalling pathway — the STING (Stimulator...

For an update on the company's progress in developing a portable brain scanner for detecting stroke, EMvision (ASX: EMV) CEO Dr Ron Weinberger joins Peter Switzer.

EMVision Medical Devices (EMV) has boosted its cash reserves over the last quarter ahead of clinical trials The company’s quarterly report for December outlined a $3.7 million increase in cash reserves to a total of $6.8 million This boo...

Cann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse, saying a global oversupply has led it to change plans. Furthermore, major shareholder Aurora says it won’t participate in any new funding r...

EMVision Medical Devices (EMV) has made significant progress in commencing clinical trials targeting stroke patients Princess Alexandra’s biomedical engineering department has completed all relevant testing of the EMV brain scanner unit in...

Medical devices are considered as an essential part of the health care industry and range from a bandage to high-risk products for implanting in the human body such as pacemakers. Medical devices differ from the general medicines as they ar...

EMVision Medical Devices Limited (ASX: EMV) receives binding commitments from the institutional and sophisticated investors to raise $4,500,000 before cost. EMV intends to utilise the funds in the commercial product development of the Comp...

In what has been described as a medical breakthrough, listed med-tech EMVision (ASX: EMV) has unveiled its prototype portable brain scanner. The brain scanner has been in development for close to a decade and will allow doctors to perform...

In what has been described as a medical breakthrough, med-tech EMVision (ASX: EMV) has unveiled its prototype portable brain scanner. The brain scanner has been in development for close to a decade and will allow doctors to perform scans...

Queensland’s EMVision Medical Devices (ASX: EMV) has announced a year-end target for clinical trials on their portable, non-invasive brain scanner for the diagnosis and monitoring of time-sensitive neurological disorders such as stroke and...

Did you know that on 16 September 2008 Lehman Brothers filed for Chapter 11 bankruptcy protection. This was the largest bankruptcy in US history and what a wild day that was for anyone working in the markets at the time. What's hot Bellamy'...